Zyla Life Sciences Debt Conversion, Converted Instrument, Amount
Zyla Life Sciences reported Debt Conversion, Converted Instrument, Amount of $24.71 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2017-03-13
- Zyla Life Sciences debt conversion, converted instrument, amount for the quarter ending 2014-12-31 was $0.00.
- Zyla Life Sciences debt conversion, converted instrument, amount for the quarter ending 2014-09-30 was $0.00.
- Zyla Life Sciences debt conversion, converted instrument, amount for the quarter ending 2014-06-30 was $0.00.
- Zyla Life Sciences debt conversion, converted instrument, amount for the quarter ending 2014-03-31 was $24.71M.
- Zyla Life Sciences debt conversion, converted instrument, amount for fiscal 2014 was $24.71M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | $0.00 derived: sum of 3 quarters · filed 2017-03-13 | $24.71M 10-K · filed 2017-03-13 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | $24.71M 10-Q · filed 2015-11-06 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $24.71M 10-Q · filed 2015-08-07 | ||
| 2014-03-31 | $24.71M 10-Q · filed 2015-05-08 |